Hijacked Commensal Gut Bacteria Promote Intestinal Foodborne Illnesses
|
By LabMedica International staff writers Posted on 24 Dec 2014 |

Image: Colonies of Escherichia coli bacteria grown on a Hektoen enteric agar plate medium (Photo courtesy of the CDC – US Centers of Disease Control and Prevention).
Though many Escherichia coli bacteria are harmless and critical to gut health, some E. coli species are harmful and can be spread through contaminated food and water, causing diarrhea and other intestinal illnesses.
The enteric pathogen enterohemorrhagic E. coli (EHEC) is the cause of severe diarrhea, but the influence of the gut microbiota on EHEC infection is largely unknown and a predominant member of the microbiota, Bacteroides thetaiotaomicron (Bt), is resident at EHEC attachment sites.
Microbiologists at the UT Southwestern Medical Center (Dallas, TX, USA) grew various strains of bacteria anaerobically and extracted ribonucleic acid (RNA) using a RiboPure Bacteria RNA isolation kit (Ambion; Grand Island, NY, USA). E. coli gene arrays were used to compare gene expression in strain EHEC O157:H7 strain 86-24 when cultured alone to that in strain 86-24 when grown in the presence of Bt. Growth curves and generation times were calculated. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was performed in a one-step reaction using an ABI 7500 sequence detection system (Applied Biosystems; Foster City, CA, USA). Fluorescein actin staining assays and histopathology were also performed.
The team discovered that EHEC uses a common gut bacterium called B. thetaiotaomicron to worsen EHEC infection. B. thetaiotaomicron is a predominant species in the gut's microbiota, which consists of tens of trillions of microorganisms used to digest food, produce vitamins, and provide a barrier against harmful microorganisms. EHEC senses changes in sugar concentrations brought about by B. thetaiotaomicron and uses this information to turn on virulence genes that help the infection colonize the gut, thwart recognition and killing by the host immune system, and obtain enough nutrients to survive.
Vanessa Sperandio, PhD, Professor of Microbiology and Biochemistry, and senior author of study said, “We are testing the idea that differential gastrointestinal microbiota compositions play an important role in determining why, in an EHEC outbreak, some people only have mild diarrhea, others have bloody diarrhea and some progress to hemolytic uremic syndrome, even though all are infected with the same strain of the pathogen.” The study was published on December 10, 2014, in the journal Cell Host Microbe.
Related Links:
UT Southwestern Medical Center
Ambion
Applied Biosystems
The enteric pathogen enterohemorrhagic E. coli (EHEC) is the cause of severe diarrhea, but the influence of the gut microbiota on EHEC infection is largely unknown and a predominant member of the microbiota, Bacteroides thetaiotaomicron (Bt), is resident at EHEC attachment sites.
Microbiologists at the UT Southwestern Medical Center (Dallas, TX, USA) grew various strains of bacteria anaerobically and extracted ribonucleic acid (RNA) using a RiboPure Bacteria RNA isolation kit (Ambion; Grand Island, NY, USA). E. coli gene arrays were used to compare gene expression in strain EHEC O157:H7 strain 86-24 when cultured alone to that in strain 86-24 when grown in the presence of Bt. Growth curves and generation times were calculated. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was performed in a one-step reaction using an ABI 7500 sequence detection system (Applied Biosystems; Foster City, CA, USA). Fluorescein actin staining assays and histopathology were also performed.
The team discovered that EHEC uses a common gut bacterium called B. thetaiotaomicron to worsen EHEC infection. B. thetaiotaomicron is a predominant species in the gut's microbiota, which consists of tens of trillions of microorganisms used to digest food, produce vitamins, and provide a barrier against harmful microorganisms. EHEC senses changes in sugar concentrations brought about by B. thetaiotaomicron and uses this information to turn on virulence genes that help the infection colonize the gut, thwart recognition and killing by the host immune system, and obtain enough nutrients to survive.
Vanessa Sperandio, PhD, Professor of Microbiology and Biochemistry, and senior author of study said, “We are testing the idea that differential gastrointestinal microbiota compositions play an important role in determining why, in an EHEC outbreak, some people only have mild diarrhea, others have bloody diarrhea and some progress to hemolytic uremic syndrome, even though all are infected with the same strain of the pathogen.” The study was published on December 10, 2014, in the journal Cell Host Microbe.
Related Links:
UT Southwestern Medical Center
Ambion
Applied Biosystems
Latest Microbiology News
- 15-Minute Blood Test Diagnoses Life-Threatening Infections in Children
- High-Throughput Enteric Panels Detect Multiple GI Bacterial Infections from Single Stool Swab Sample
- Fast Noninvasive Bedside Test Uses Sugar Fingerprint to Detect Fungal Infections
- Rapid Sepsis Diagnostic Device to Enable Personalized Critical Care for ICU Patients
- Microfluidic Platform Assesses Neutrophil Function in Sepsis Patients
- New Diagnostic Method Confirms Sepsis Infections Earlier
- New Markers Could Predict Risk of Severe Chlamydia Infection
- Portable Spectroscopy Rapidly and Noninvasively Detects Bacterial Species in Vaginal Fluid
- CRISPR-Based Saliva Test Detects Tuberculosis Directly from Sputum
- Urine-Based Assay Diagnoses Common Lung Infection in Immunocompromised People
- Saliva Test Detects Implant-Related Microbial Risks
- New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance
- Early Detection of Gut Microbiota Metabolite Linked to Atherosclerosis Could Revolutionize Diagnosis
- Viral Load Tests Can Help Predict Mpox Severity
- Gut Microbiota Analysis Enables Early and Non-Invasive Detection of Gestational Diabetes
- Credit Card-Sized Test Boosts TB Detection in HIV Hotspots
Channels
Clinical Chemistry
view channel
Mismatch Between Two Common Kidney Function Tests Indicates Serious Health Problems
Creatinine has long been the standard for measuring kidney filtration, while cystatin C — a protein produced by all human cells — has been recommended as a complementary marker because it is influenced... Read more
VOCs Show Promise for Early Multi-Cancer Detection
Early cancer detection is critical to improving survival rates, but most current screening methods focus on individual cancer types and often involve invasive procedures. This makes it difficult to identify... Read moreMolecular Diagnostics
view channel
New DNA Test Tracks Spread of Parasitic Disease from Single Sample
Leishmaniasis remains a major challenge for veterinary and public health systems, largely because its transmission involves multiple sand fly species and a wide range of animal hosts. Understanding these... Read more
Hidden Blood Biomarkers to Revolutionize Diagnosis of Diabetic Kidney Disease
Diabetic kidney disease often develops silently, and many patients are diagnosed only after irreversible damage has occurred. Late diagnosis frequently leads to complications affecting the kidneys, heart,... Read moreHematology
view channel
Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk
Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more
Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients
Assessing disease severity in sickle cell disease (SCD) remains challenging, especially when trying to predict hemolysis, vascular injury, and risk of complications such as vaso-occlusive crises.... Read more
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read moreImmunology
view channel
Chip Captures Cancer Cells from Blood to Help Select Right Breast Cancer Treatment
Ductal carcinoma in situ (DCIS) accounts for about a quarter of all breast cancer cases and generally carries a good prognosis. This non-invasive form of the disease may or may not become life-threatening.... Read more
Blood-Based Liquid Biopsy Model Analyzes Immunotherapy Effectiveness
Immunotherapy has revolutionized cancer care by harnessing the immune system to fight tumors, yet predicting who will benefit remains a major challenge. Many patients undergo costly and taxing treatment... Read morePathology
view channel
Simple Optical Microscopy Method Reveals Hidden Structures in Remarkable Detail
Understanding how microscopic fibers are organized in human tissues is key to revealing how organs function and how diseases disrupt them. However, these fiber networks have remained difficult to visualize... Read more
Hydrogel-Based Technology Isolates Extracellular Vesicles for Early Disease Diagnosis
Isolating extracellular vesicles (EVs) from biological fluids is essential for early diagnosis, therapeutic development, and precision medicine. However, traditional EV-isolation methods rely on ultra... Read moreTechnology
view channel
AI Saliva Sensor Enables Early Detection of Head and Neck Cancer
Early detection of head and neck cancer remains difficult because the disease produces few or no symptoms in its earliest stages, and lesions often lie deep within the head or neck, where biopsy or endoscopy... Read more
AI-Powered Biosensor Technology to Enable Breath Test for Lung Cancer Detection
Detecting lung cancer early remains one of the biggest challenges in oncology, largely because current tools are invasive, expensive, or unable to identify the disease in its earliest phases.... Read moreIndustry
view channel
Abbott Acquires Cancer-Screening Company Exact Sciences
Abbott (Abbott Park, IL, USA) has entered into a definitive agreement to acquire Exact Sciences (Madison, WI, USA), enabling it to enter and lead in fast-growing cancer diagnostics segments.... Read more








